Log in to save to my catalogue

Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with ne...

Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with ne...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3195634512

Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma

About this item

Full title

Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of cancer research and clinical oncology, 2020-03, Vol.146 (3), p.787-792

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
In the EF-14 trial for newly diagnosed glioblastoma (ndGBM) patients addition of Tumour Treating Fields (TTFields) to temozolomide treatment resulted in a significantly improved overall survival (OS). In the NOA-09/CeTeG trial, combination of lomustine and temozolomide was superior to temozolomide monotherapy in patients with O6-methylgu...

Alternative Titles

Full title

Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_3195634512

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_3195634512

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s00432-019-03106-8

How to access this item